Defining a pathway for mitochondrial heme trafficking
定义线粒体血红素运输途径
基本信息
- 批准号:10733705
- 负责人:
- 金额:$ 54.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:ABCG2 geneAnabolismAnemiaAsthmaAutoimmunityAzolesBindingBiologicalBiological ProcessBiotinylationCYP2D6 geneCYP3A4 geneCardiovascular systemCell Culture TechniquesCell membraneCellsChargeChimeric ProteinsComplexCrystallizationCrystallographyCytochrome P450DioxygenasesDiseaseDrug ControlsElectron TransportEnzymesEukaryotaEventGoalsHealthHemeHemeproteinsHemoglobinHereditary DiseaseHumanImmune systemInfectionIronKineticsKnowledgeLungMammalian CellMammalsMedicalMissionMitochondriaModificationMolecularMolecular ChaperonesMonitorMutagenesisMyoglobinNADPH OxidaseNational Institute of General Medical SciencesNeurologicNitric Oxide SynthaseOrganismPathway interactionsPeroxidasesPharmaceutical PreparationsPhysiologyPlayProductionPropertyProteinsPublishingRegulationResearchRoleSignal TransductionSiteSoluble Guanylate CyclaseSourceSteroid biosynthesisStructureSurfaceSystemTestingTransport ProcessVasodilationWorkYeastscofactorcrosslinkexperimental studyheme aheme oxygenase-1heme oxygenase-2indoleaminemutantparticleprotein complexprotein functionprotein purificationreconstitutionsensortraffickingtumor
项目摘要
ABSTRACT
Hemeproteins play vital transport, enzymatic, and signaling roles that fundamentally impact our cardiovascular,
pulmonary, digestive, neurological, and immune systems. Cells must transport mitochondrial heme to proteins
that mature and function outside the mitochondria. Our goal is to understand how intracellular heme delivery
takes place and is regulated in mammals. Cytosolic heme delivery proteins have been postulated but their
identities are unclear. We found that GAPDH binds mitochondrially-generated heme and that its heme binding
is essential for delivery to eight different hemeprotein targets. We hypothesize that GAPDH-dependent heme
delivery is fundamental for hemeprotein function, and we propose to discern mechanisms, scope, and
regulation of GAPDH-dependent heme delivery. Our experiments utilize purified proteins and cell culture,
which provides a facile path to molecular-level discoveries and a robust means to validate their biological
relevance. We have ways to control cell heme production, monitor GAPDH-heme binding and transfer in live
cells and between proteins, assess heme delivery to targets, characterize GAPDH-target complexes, and
determine their relevance for heme delivery.
AIM 1. How does GAPDH participate in intracellular heme delivery? We hypothesize GAPDH may bind
directly to the target proteins to deliver heme and found it does so with at least four proteins (apo-sGCβ, IDO1,
TDO, and Mb) in cells and purified form. We will: (i) identify interface regions in each GAPDH-hemeprotein
complex using HDx-MS, MS-cleavable crosslinking, and NMR approaches; (ii) use mutagenesis to test the role
of GAPDH-target protein contacts in heme deliveries; (iii) structurally characterize the GAPDH-heme complex
and GAPDH-hemeprotein complexes by crystallography and single particle EM; (iv) utilize a GAPDH-biolD2-HA
fusion protein to biotinylate intermediate or middleman proteins that associate with GAPDH during heme
transfers; (v) deploy GAPDH surface charge mutants to independently probe GAPDH-target binding and role in
heme transfers; (vi) perform heme transfer experiments with purified GAPDH & target proteins; (vii) screen for
GAPDH-dependent heme deliveries to cell heme exporters (FLVCR1a & ABCG2), cytochrome P450’s (CYP2D6
& CYP3A4), two peroxidases (LPO & EPO), an NADPH oxidase (NOX5), and heme oxygenases 1 & 2.
AIM 2. What controls GAPDH heme acquisition & deliveries? Cell & molecular mechanisms that control
GAPDH heme acquisition and release are unknown. We will: (i) determine if mitochondrial heme exporter
FLVCR1b and/or ER heme exporter PGRMC2 is a heme source for GAPDH; (ii) test if GAPDH heme acquisition
involves direct interaction with the exporters; (iii) investigate if GAPDH-heme level in cells is regulated by cell
heme exporters FLVCR1a & ABCG2; (iv) examine if post-translational GAPDH modification, chaperone hsp90,
or azole drugs control GAPDH heme acquisition and delivery.
抽象的
囊蛋白起着重要的运输,酶促和信号传导作用,从根本上影响我们的心血管,
细胞必须将线粒体血红素传输到蛋白质
线粒体之外的成熟和功能。我们的目标是了解细胞内血红素的递送
发生并受到哺乳动物的调节。胞质血红素递送蛋白已发布,但他们的
身份尚不清楚。我们发现GAPDH结合了线粒体生成的血红素,其血红素结合
对于送到八种不同的止血蛋白靶标的至关重要。我们假设GAPDH依赖性血红素
递送是易血蛋白功能至关重要的,我们建议辨别机制,范围和
调节GAPDH依赖性血红素递送。我们的实验利用纯化的蛋白质和细胞培养,
这为分子级发现提供了简便的路径,并且可以验证其生物学的强大手段
关联。我们有控制细胞血红素产生的方法
细胞和蛋白质之间,评估血红素到靶标的血红素递送,表征GAPDH靶络合物,并
确定它们与血红素交付的相关性。
目标1。GAPDH如何参与细胞内血红素递送?我们假设GAPDH可能会结合
直接到靶蛋白输送血红素,并发现至少四个蛋白质(apo-sgcβ,ido1,
TDO和MB)在细胞和纯化的形式中。我们将:(i)识别每个GAPDH-蛋白质中的接口区域
使用HDX-MS,MS可裂解的交联和NMR方法的复合物; (ii)使用诱变测试角色
血红素输送中的GAPDH靶蛋白接触; (iii)在结构上表征了GAPDH - 血红素复合物
通过晶体学和单个颗粒EM进行的GAPDH-HEMEPROTEIN复合物; (iv)使用GAPDH-biold2-ha
在血红素期间与GAPDH相关的融合蛋白与生物素化中间或中间人蛋白
转移; (v)将GAPDH表面电荷突变体部署到独立探测GAPDH靶标结合和在
血红素转移; (vi)用纯化的GAPDH和靶蛋白执行血红素转移实验; (vii)屏幕
GAPDH依赖性血红素输送到细胞血红素出口商(FLVCR1A和ABCG2),细胞色素P450(CYP2D6)
&CYP3A4),两个过氧化物酶(LPO和EPO),一个NADPH氧化酶(NOX5)和血红素氧酶1和2。
目标2。是什么控制了GAPDH血红素的收购和交付?控制的细胞和分子机制
GAPDH血红素的获取和释放尚不清楚。我们将:(i)确定线粒体血红素出口商是否
FLVCR1b和/或ER血红素出口商PGRMC2是GAPDH的血红素来源; (ii)测试GAPDH血红素是否获得
涉及与出口商的直接互动; (iii)调查细胞中的GAPDH - 血液水平是否受细胞调节
血红素出口商flvcr1a&abcg2; (iv)检查如果翻译后的GAPDH修饰,伴侣HSP90,
或Azole药物控制GAPDH血红素的获取和输送。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS J STUEHR其他文献
DENNIS J STUEHR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS J STUEHR', 18)}}的其他基金
Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxide
细胞伴侣、血红素和一氧化氮协调控制血红素蛋白的成熟和功能
- 批准号:
10207671 - 财政年份:2019
- 资助金额:
$ 54.42万 - 项目类别:
Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxide
细胞伴侣、血红素和一氧化氮协调控制血红素蛋白的成熟和功能
- 批准号:
10428556 - 财政年份:2019
- 资助金额:
$ 54.42万 - 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
- 批准号:
8241962 - 财政年份:2011
- 资助金额:
$ 54.42万 - 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
- 批准号:
8636030 - 财政年份:2011
- 资助金额:
$ 54.42万 - 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
- 批准号:
8449268 - 财政年份:2011
- 资助金额:
$ 54.42万 - 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
- 批准号:
8082579 - 财政年份:2011
- 资助金额:
$ 54.42万 - 项目类别:
2009 Nitric Oxide Gordon Research Conference
2009 年一氧化氮戈登研究会议
- 批准号:
7600784 - 财政年份:2009
- 资助金额:
$ 54.42万 - 项目类别:
Nitric Oxide Synthases As Oxidative And Therapeutic Agents
作为氧化剂和治疗剂的一氧化氮合成酶
- 批准号:
7664775 - 财政年份:2008
- 资助金额:
$ 54.42万 - 项目类别:
Redor Pathways Regulating Nemeprotein Maturation in Asthma
Redor 通路调节哮喘中的 Neme 蛋白成熟
- 批准号:
9232190 - 财政年份:2006
- 资助金额:
$ 54.42万 - 项目类别:
Redor Pathways Regulating Nemeprotein Maturation in Asthma
Redor 通路调节哮喘中的 Neme 蛋白成熟
- 批准号:
9015473 - 财政年份:2006
- 资助金额:
$ 54.42万 - 项目类别:
相似国自然基金
三氧化二砷通过抑制骨髓巨噬细胞糖代谢重编程治疗再生障碍性贫血的机制研究
- 批准号:82370143
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
异功散通过促进巨噬细胞线粒体自噬负向调控NLRP3炎症小体改善慢性病贫血铁代谢的机制研究
- 批准号:82104778
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
异功散通过促进巨噬细胞线粒体自噬负向调控NLRP3炎症小体改善慢性病贫血铁代谢的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从ActinvinB竞争性结合BMP受体调节hepcidin-ferroportin轴研究异功散改善慢性病贫血铁代谢的作用机制
- 批准号:81804021
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
从VEGFR-3负反馈抑制TLR4-NF-κB信号通路的作用探讨异功散对慢性病贫血脾脏巨噬细胞铁代谢的调节机制
- 批准号:81774271
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
相似海外基金
Renal endothelium and the development of chronic kidney disease in sickle cell disorders
镰状细胞病中的肾内皮和慢性肾病的发展
- 批准号:
10659575 - 财政年份:2023
- 资助金额:
$ 54.42万 - 项目类别:
2022 Chemistry and Biology of Tetrapyrroles Gordon Research Conference
2022年四吡咯化学与生物学戈登研究会议
- 批准号:
10527747 - 财政年份:2022
- 资助金额:
$ 54.42万 - 项目类别:
Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell Disorders
镰状细胞病肾病的分子和细胞发病机制
- 批准号:
10542842 - 财政年份:2021
- 资助金额:
$ 54.42万 - 项目类别:
Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell Disorders
镰状细胞病肾病的分子和细胞发病机制
- 批准号:
10117308 - 财政年份:2021
- 资助金额:
$ 54.42万 - 项目类别: